Download PDF
Synfacts 2022; 18(08): 0838
DOI: 10.1055/s-0041-1738230
Synthesis of Natural Products and Potential Drugs

Synthesis of a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor

Contributor(s):
Philip Kocienski
› Further Information
    Permissions and Reprints

Key words

S-217622 - COVID-19 - SARS-CoV-2 3CL protease inhibitor


Publication History

Article published online:
18 July 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany